Stay updated on SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial

Sign up to get notified when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and v3.2.0 was removed. This update does not modify the study details, eligibility criteria, endpoints, or other substantive content on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:47:45.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Removed the government funding/operating-status notice at the top of the page; no core study data or critical content were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:23:32.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The study details page shows no significant updates; core information including eligibility criteria and primary outcomes appears unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T21:02:43.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Version bump to v3.2.0 accompanied by a government-operating-status notice; replaces the earlier v3.1.0 tag.
    Difference
    3%
    Check dated 2025-10-06T08:58:05.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.2%
    Check dated 2025-09-29T07:29:17.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision: v3.0.2 is now displayed, replacing v3.0.1, and the Back to Top element was removed; this is a minor update with no changes to core content, pricing, stock availability, or time slot information.
    Difference
    0.2%
    Check dated 2025-09-14T23:11:02.000Z thumbnail image

Stay in the know with updates to SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.